Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study

BACKGROUND: As more patients are treated by haematopoietic stem cell transplantation (HSCT), development of secondary malignancy (SM) becomes an increasingly common issue in long-term survivors. METHODS: We conducted a nationwide population-based study of the Taiwanese population to analyse patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, S-H, Liu, C-J, Hong, Y-C, Teng, C-J, Hu, Y-W, Shen, C-C, Ku, F-C, Chen, S-C, Yeh, C-M, Chiou, T-J, Gau, J-P, Tzeng, C-H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453596/
https://www.ncbi.nlm.nih.gov/pubmed/25314066
http://dx.doi.org/10.1038/bjc.2014.523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453596/
https://www.ncbi.nlm.nih.gov/pubmed/25314066
http://dx.doi.org/10.1038/bjc.2014.523

Ejemplares similares